GGrantIndex
Sort

34,240 grants matching atherosclerosis

Inflammasome activation in an SIV-ART model of chronic drug abuse

$708,686
Janice Ellen Clements · Johns Hopkins University · R01 · FY2021 · DA

Inflammasome activation in an SIV-ART model of chronic drug abuse

$708,686
Janice Ellen Clements · Johns Hopkins University · R01 · FY2020 · DA

Acetate and Endothelial Pathobiology

$708,532
Zoltan P Arany · University Of Pennsylvania · R01 · FY2025 · HL

Trial of a harm reduction strategy for people with HIV who smoke cigarettes

$708,492
Jonathan Shuter · Albert Einstein College Of Medicine · R01 · FY2024 · CA

Trial of a harm reduction strategy for people with HIV who smoke cigarettes

$708,477
Jonathan Shuter · Albert Einstein College Of Medicine · R01 · FY2025 · CA

SPPACE INSTI Study: Sex-specific Predictors, Pathways, And Cardiometabolic Effects of Weight Gain Associated with Integrase Strand-Transfer Inhibitors

$708,471
Cecile Delille Lahiri · Emory University · R01 · FY2023 · DK

Molecular Determinants of Atherosclerotic Cardiovascular Disease in Multi-ethnic Populations

$708,350
Bing Yu · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · HL

Rare Variants for Hypertension in Taiwan Chinese

$708,340
Dabeeru C Rao · Washington University · R01 · FY2015 · HL

The Role of SALTe1 in Vascular Aging and Heart Failure With Preserved Ejection Fraction

$708,266
Haobo Li · Massachusetts General Hospital · R01 · FY2025 · HL

Carotid plaque characteristics by MRI in AIM-HIGH

$708,181
Xue-Qiao Zhao · University Of Washington · R01 · FY2009 · HL

MECHANISM OF SELENOPEROXIDASE BIOSYNTHESIS

$708,131
Donna M Driscoll · Cleveland Clinic Lerner Com-Cwru · P01 · FY2007 · HL

Clinical and Genetic Correlates of Vascular Function in African Americans: JHS

$708,114
Ervin R Fox · University Of Mississippi Med Ctr · R01 · FY2012 · HL

T-cell subsets as CVD risk factors in CHS and MESA

$707,950
Bruce M Psaty · University Of Washington · R01 · FY2015 · HL

Plaque and blood derived macrophages: a multi-omic assessment of CVD pathogenesis in PLWH

$707,936
Nicholas T. Funderburg · Ohio State University · R01 · FY2022 · HL

Prognostic Implications of Home-Based Blood Pressure Monitoring in Older Adults

$707,769
Stephen P Juraschek · Beth Israel Deaconess Medical Center · R01 · FY2024 · HL

Longitudinal Study of Predictors and Consequences of Chronic Kidney Disease

$707,660
Brad C Astor · Johns Hopkins University · R01 · FY2008 · DK

Characterization of Coagulation Factor-platelet Interactions: Role of FXI

$707,631
Owen J McCarty · Oregon Health & Science University · R01 · FY2019 · HL

Reproducibility and Clinical Implications of Masked Hypertension

$707,599
Anthony J Viera · Univ Of North Carolina Chapel Hill · R01 · FY2012 · HL

Targeted editing of ASGR1 for cardiovascular diseases

$707,525
Renzhi Han · Indiana University Indianapolis · R01 · FY2025 · HL

Glia maturation factor-gamma modulation of signaling pathways in macrophages

$707,429
Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL

T Regulatory Lymphocytes, HDL Function, and Atherosclerosis

$707,427
Catherine C Hedrick · La Jolla Institute For Immunology · R01 · FY2013 · HL

Changes in arterial stiffness, cognition and dementia risk in a diverse cohort

$707,362
Michelle Meyer · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AG

Informing best practices for evaluation and treatment of myocardial injury during sepsis

$707,275
Allan J. Walkey · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · HL

Novel Regulators of Calcific Aortic Valve Disease

$707,264
Mehran M Sadeghi · Yale University · R01 · FY2020 · HL

Linking microbiome genetic variants with cardiovascular phenotypes in 50,000 individuals

$707,257
Katherine Snowden Pollard · J. David Gladstone Institutes · R01 · FY2022 · HL